Clinical Trial Update: DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase II randomized trial comparing DC-CIK immunotherapy plus chemotherapy (Oxaliplatin or Cisplatin) against first-li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DC-CIK
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Beijing Biohealthcare Biotechnology Co.,Ltd | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN